The prostate-specific membrane antigen (PSMA) PET/CT and mpMRI have comparable diagnostic accuracy in the discovery and intraprostatic localization of prostate cancer foci whereas mpMRI makes better in the assessment of extracapsular extension (ECE) and seminal vesicle invasion (SVI) [37]. Here, FOLH1 is linked to prostate carcinoma.